Payer+Provider's Health System Review
Medicare Advantage’s Popularity Shows Americans Won’t Like Single-Payer
Health care is expensive. It’s time to treat the cause.
October 29, 2018
Nasdaq-listed Nucana has some promising cancer therapies in drug trials and an experienced leader.
Read the full post on Forbes - Healthcare